IMPACT OF MULTI-TIERED PHARMACY BENEFITS ON MEDICATION ADHERENCE

Author(s)

Valuck RJ1, Nair K1, Wolfe P2, McCollum M1, Lewis S3, 1University of Colorado School of Pharmacy, Denver, CO, USA; 2Wolfe Statistical Consulting, LLC, Denver, CO, USA; 3Anthem Blue Cross Blue Shield of Colorado, Denver, CO, USA

OBJECTIVE: To examine the impact of two and three-tiered prescription drug benefits on medication adherence rates among managed care patients with selected chronic conditions. METHODS: Quasi-experimental, pre-post with comparison groups design using 6109 adult patients in a large, western U.S. managed care organization with one or more of the following conditions: arthritis, diabetes, dyslipidemia, GERD, or hypertension. The intervention group consisted of members whose prescription drug coverage converted from a 2-tier to a 3-tier benefit (n=4239). Comparison groups included those whose benefits remained in a 2-tier (n=592) or 3-tier (n=1278) structure. Medication adherence rates were measured in the pre and post periods using the medication possession ratio. Demographic and attitudinal measures were obtained from a mail survey during the pre period. Statistical analyses were based on maximum likelihood estimates from a repeated measures model to test for differences in medication adherence controlling for the effects of demographic variables, health status, comorbid diseases, pharmacy plan type, and patient satisfaction. RESULTS: Adherence rates ranged from 90.4% to 95.5% in the pre period. The mean adherence rate in the intervention group decreased from 94.7% (pre period) to 90.2% (post period), a decrease of 4.5%. Similar decreases occurred in the comparison groups: from 95.5% to 91.7% (-3.8%) for 2-tier subjects, and from 92.9% to 90.4% (-2.5%) for 3-tier subjects. The decrease in the intervention group was significantly larger than the decrease in the 3-tier subjects (p=0.0003) but not statistically different from the decrease observed in the 2-tier subjects (p=0.27). Adherence increased slightly as age and number of chronic conditions increased. No relationship was observed between medication adherence and patient satisfaction (p=0.35 in the pre period). CONCLUSION: Medication adherence rates were high in the population studied. Changes in benefit design (from 2 to 3-tier drug benefits) had no appreciable impact on adherence.

Conference/Value in Health Info

2002-05, ISPOR 2002, Arlington, VA, USA

Value in Health, Vol. 5, No. 3 (May/June 2002)

Code

PHP5

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Formulary Development

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×